ArticlePreventive medicine2026
Stagnating declines in cardiovascular disease mortality in the United States expanded the black-white life expectancy gap.
Article in Preventive medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Psychometric Evidence for Chronic Stress Patient-Reported Outcome Measures in African American Adults: An Equity-Focused COSMIN Systematic Review.Journal of racial and ethnic health disparities · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
objectiveTo assess how stagnation in cardiovascular disease (CVD) mortality declines since 2010 impacted racial disparities in life expectancy between Black and White Americans.
methodsWe analyzed U.S. vital statistics from 2000 to 2022 to compare age-standardized CVD mortality trends in Black and White middle-aged and older adults. Using life tables, we then estimated racial differences in life expectancy under observed mortality conditions and under a counterfactual scenario in which CVD mortality had continued to decline in 2010-2022 at pre-2010 rates.
resultsIn 2000-2009, CVD mortality was declining more quickly among Black Americans, and the Black-White life expectancy gap narrowed by 1.39 years for women and 1.44 years for men. Progress slowed after 2010. Had pre-2010 CVD mortality trends continued, Black women would have lived 2.04 years longer in 2019, narrowing the 1.88-year Black-White life expectancy gap by 0.43 years. If improvements had continued through 2022, Black women would have lived 2.83 years longer, translating to a 0.64-year reduction in the Black-White life expectancy gap. Men exhibited a similar pattern with a smaller effect.
conclusionsThe post-2010 slowdown in CVD mortality declines disproportionately limited longevity gains for Black Americans, especially Black women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.